Cancer Antigen 125 (CA-125)
CA-125 is a protein biomarker often used to monitor the treatment and progression of ovarian cancer.
CA-125 is primarily used to monitor ovarian cancer treatment and progression.
Key facts at a glance
- Units
- U/mL
- Clinical utility
- monitoring
- Result kind
- quantitative
- FDA-cleared
- Roche CA 125, Abbott CA 125, Siemens CA 125, Beckman CA 125
CA-125, or Cancer Antigen 125, is a protein that is often found on the surface of ovarian cancer cells and can be detected in the blood. Elevated levels of CA-125 are commonly associated with ovarian cancer, although they can also be elevated in other conditions such as endometriosis, uterine fibroids, and even during pregnancy.
In the context of oncology, CA-125 is primarily used to monitor the effectiveness of treatment for ovarian cancer and to detect disease recurrence. A decrease in CA-125 levels often indicates a positive response to treatment, while an increase may suggest disease progression or recurrence.
While CA-125 is a valuable tool in managing ovarian cancer, it is not used as a screening test due to its lack of specificity. Other diagnostic tests and clinical assessments are necessary to confirm a diagnosis of ovarian cancer.
Frequently asked questions
What does a high CA-125 level mean?
Is CA-125 used for screening?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy